Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Variables Related to Working Capability among Swiss Patients with Multiple Sclerosis-A Cohort Study.
Promoting Physical Activity through a Manual Wheelchair Propulsion Intervention in Persons with Multiple Sclerosis.
Cancer drug shows promise for multiple sclerosis.
Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens.
Auraptene induces oligodendrocyte lineage precursor cells in a cuprizone-induced animal model of demyelination.
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Incidence of Radiologically Isolated Syndrome: A Population-Based Study.
Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.
L-periaxin interacts with S-periaxin through its PDZ domain.
Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients.
Evaluation of axonal optic nerve damage using visual evoked potentials and optical coherence tomography in patients with multiple sclerosis.
Current topics in therapeutic plasmapheresis.
A Patient-defined "Best Case" of Multiple Sclerosis Related to the Use of Complementary and Alternative Medicine.
Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination.
C9ORF72 repeat expansion not detected in patients with multiple sclerosis.
Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab.
Systematic review of clinical practice guidelines related to multiple sclerosis.
[Tryptophan immunoadsorption for multiple sclerosis and neuromyelitis optica : Therapy option for acute relapses during pregnancy and breastfeeding.]
Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.
Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Challenges and opportunities in designing clinical trials for neuromyelitis optica.
The economic impact of multiple sclerosis in Australia in 2010.
Pages
« first
‹ previous
…
583
584
585
586
587
588
589
590
591
…
next ›
last »